SCOPUS 정보 검색 플랫폼

Critical Care Medicine

Volumn 42, Issue 12, 2014, Pages e797-e798

Addressing the global burden of sepsis: Importance of a systems-based approach to the editor

(1) Dobson, Geoffrey P a

a JAMES COOK UNIVERSITY (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; CARDIOVASCULAR AGENT; VASODILATOR AGENT; FIBRINOLYTIC AGENT; PROTEIN C;

BLEEDING; CLINICAL DATA REPOSITORY; HUMAN; INFLAMMATION; LETTER; MEDICAL INFORMATION SYSTEM; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RESUSCITATION; SEPSIS; SEPTIC SHOCK; TISSUE OXYGENATION; VASCULAR ENDOTHELIUM; PROCEDURES;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; FIBRINOLYTIC AGENTS; HUMANS; PROTEIN C; SEPSIS;

EID: 84922514804 PISSN: 00903493 EISSN: 15300293 Source Type: Journal
DOI: 10.1097/CCM.0000000000000595 Document Type: Letter

Times cited : (13)

References (8)

1
- 84886687567
- The burden of sepsis-a call to action in support of World Sepsis Day 2013
- Reinhart K, Daniels R, Kissoon N, et al; GSA Executive Board and WSD Executive Board: The burden of sepsis-a call to action in support of World Sepsis Day 2013. J Crit Care 2013;28:526-528
- (2013) J Crit Care , vol.28 , pp. 526-528
- GSA Executive Board and WSD Executive Board¹ Reinhart, K.² Daniels, R.³ Kissoon, N.⁴

2
- 84902511727
- The Next Generation of Sepsis Clinical Trial Designs: What is Next After the Demise of Recombinant Human Activated Protein C?
- Opal SM, Dellinger RP, Vincent JL, et al: The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C? Crit Care Med 2014;42:1714-1721
- (2014) Crit Care Med , vol.42 , pp. 1714-1721
- Opal, S.M.¹ Dellinger, R.P.² Vincent, J.L.³

3
- 77950542304
- Pathophysiology, monitoring, and therapy of shock with organ failure
- Shoemaker WC, Beez M: Pathophysiology, monitoring, and therapy of shock with organ failure. Appl Cardiopulmonary Pathophyiol 2010;14:5-15
- (2010) Appl Cardiopulmonary Pathophyiol , vol.14 , pp. 5-15
- Shoemaker, W.C.¹ Beez, M.²

4
- 84873339299
- Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012
- Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637
- (2013) Crit Care Med , vol.41 , pp. 580-637
- Dellinger, R.P.¹ Levy, M.M.² Rhodes, A.³

5
- 84889239723
- Sepsis and scientific revolutions
- Artenstein AW, Higgins TL, Opal SM: Sepsis and scientific revolutions. Crit Care Med 2013;41:2770-2772
- (2013) Crit Care Med , vol.41 , pp. 2770-2772
- Artenstein, A.W.¹ Higgins, T.L.² Opal, S.M.³

6
- 30044451330
- Oakville, CT, David Brown and Co
- Dobson GP: A Chaos of Delight: Science, Religion and Myth and the Shaping of Western Thought. Oakville, CT, David Brown and Co, 2005
- (2005) A Chaos of Delight: Science, Religion and Myth and the Shaping of Western Thought
- Dobson, G.P.¹

7
- 34249326963
- Mechanisms of sepsis-induced cardiac dysfunction
- Rudiger A, Singer M: Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007;35:1599-1608
- (2007) Crit Care Med , vol.35 , pp. 1599-1608
- Rudiger, A.¹ Singer, M.²

8
- 84555189016
- Resuscitative strategies to maintain homeostasis during damage control surgery
- Dutton RP: Resuscitative strategies to maintain homeostasis during damage control surgery. Br J Surg 2012;99(Suppl 1):21-28
- (2012) Br J Surg , vol.99 , pp. 21-28
- Dutton, R.P.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.